INTRODUCTION

Aldesleukin is a modified human interleukin-2 produced in an engineered E.coli expression system. It is a drug used in the treatment of renal cell carcinoma and melanoma.

This plasmid is designed for expession of aldesleukin in E.coli cells.

PRODUCT INFORMATION

Item No.: PPBD-7
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options for promoter and antibiotic selection marker, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Aldesleukin
Trade Name: Proleukin
Target: Human interleukin-2 receptor subunit beta, human interleukin-2 receptor subunit alpha, human cytokine receptor common subunit gamma
Action Type: Agonist
Amino Acid Sequence: Identical to DB00041

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

Contact Us